应对2型循环疫苗衍生脊髓灰质炎病毒暴发的策略响应——叙利亚,2017-2018年
2017年5-6月,叙利亚代尔祖尔省两名急性弛缓性麻痹儿童的粪便标本中分离出2型疫苗衍生脊髓灰质炎病毒(VDPV2),基因序列分析确认两例相关,构成2型循环疫苗衍生脊髓灰质炎病毒(cVDPV2)暴发。叙利亚加强脊髓灰质炎监测,并针对5岁以下儿童开展三轮以2型单价口服脊髓灰质炎疫苗(mOPV2)为基础的疫苗接种活动。暴发期间共发现74例cVDPV2病例,最近一例发生于2017年9月。证据表明,加强监测措施结合mOPV2疫苗接种活动已阻断叙利亚cVDPV2传播。
要点
- 2017年5-6月叙利亚代尔祖尔省两名急性弛缓性麻痹儿童粪便标本分离出VDPV2,基因序列分析确认两例相关,构成cVDPV2暴发。
- 叙利亚加强脊髓灰质炎监测,并针对5岁以下儿童开展三轮mOPV2疫苗接种活动。
- 暴发期间共发现74例cVDPV2病例,最近一例发生于2017年9月;证据表明加强监测结合mOPV2接种已阻断传播。
核心结论
- 证据表明,加强监测措施结合mOPV2疫苗接种活动已阻断叙利亚cVDPV2传播。
研究设计与样本
- 暴发调查与应对:2017年5-6月叙利亚代尔祖尔省两名急性弛缓性麻痹儿童粪便标本分离出VDPV2,基因序列分析确认两例相关,构成cVDPV2暴发。
主要发现
- 第一株分离株与Sabin疫苗病毒在VP1编码区(903个核苷酸)相差22个核苷酸。
- 基因序列分析将两例关联,确认cVDPV2暴发。
- 暴发期间共发现74例cVDPV2病例,最近一例发生于2017年9月。
关键数值与推荐
- 2016年4月全球同步从三价口服脊髓灰质炎疫苗(tOPV,含疫苗病毒1、2、3型)转换为二价口服脊髓灰质炎疫苗(bOPV,含1、3型)后,全球消灭脊髓灰质炎倡议(GPEI)将任何VDPV2出现视为公共卫生紧急事件。
- 疫苗接种活动针对5岁以下儿童,使用2型单价口服脊髓灰质炎疫苗(mOPV2),共开展三轮。
临床怎么用
- 加强脊髓灰质炎监测并针对5岁以下儿童开展三轮mOPV2疫苗接种活动。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since the 1988 inception of the Global Polio Eradication Initiative (GPEI), progress toward interruption of wild poliovirus (WPV) transmission has occurred mostly through extensive use of oral poliovirus vaccine (OPV) in mass vaccination campaigns and through routine immunization services (1,2). However, because OPV contains live, attenuated virus, it carries the rare risk for reversion to neurovirulence. In areas with very low OPV coverage, prolonged transmission of vaccine-associated viruses can lead to the emergence of vaccine-derived polioviruses (VDPVs), which can cause outbreaks of paralytic poliomyelitis. Although WPV type 2 has not been detected since 1999, and was declared eradicated in 2015,* most VDPV outbreaks have been attributable to VDPV serotype 2 (VDPV2) (3,4). After the synchronized global switch from trivalent OPV (tOPV) (containing vaccine virus types 1, 2, and 3) to bivalent OPV (bOPV) (types 1 and 3) in April 2016 (5), GPEI regards any VDPV2 emergence as a public health emergency (6,7). During May-June 2017, VDPV2 was isolated from stool specimens from two children with acute flaccid paralysis (AFP) in Deir-ez-Zor governorate, Syria. The first isolate differed from Sabin vaccine virus by 22 nucleotides in the VP1 coding region (903 nucleotides). Genetic sequence analysis linked the two cases, confirming an outbreak of circulating VDPV2 (cVDPV2). Poliovirus surveillance activities were intensified, and three rounds of vaccination campaigns, aimed at children aged <5 years, were conducted using monovalent OPV type 2 (mOPV2). During the outbreak, 74 cVDPV2 cases were identified; the most recent occurred in September 2017. Evidence indicates that enhanced surveillance measures coupled with vaccination activities using mOPV2 have interrupted cVDPV2 transmission in Syria.
引用
- Mbaeyi C, Wadood ZM, Moran T, et al. Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2 - Syria, 2017-2018. MMWR Morb Mortal Wkly Rep. 2018. PMID: 29927908. doi:10.15585/mmwr.mm6724a5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。